151563-36-9 Usage
Description
(-)-10-epiteuclatriol is a diterpenoid chemical compound derived from the roots of the plant Eucladium verticillatum. It has been found to exhibit anti-inflammatory and antioxidant properties, making it a promising candidate for pharmaceutical and medical applications.
Uses
Used in Pharmaceutical Industry:
(-)-10-epiteuclatriol is used as a therapeutic agent for the treatment of inflammatory and oxidative stress-related diseases due to its anti-inflammatory and antioxidant properties.
Used in Medical Research:
(-)-10-epiteuclatriol is used as a research compound for further investigation into its molecular structure and biological activity, with the aim of developing new pharmaceutical and medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 151563-36-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,5,6 and 3 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 151563-36:
(8*1)+(7*5)+(6*1)+(5*5)+(4*6)+(3*3)+(2*3)+(1*6)=119
119 % 10 = 9
So 151563-36-9 is a valid CAS Registry Number.
151563-36-9Relevant articles and documents
Traceless Stereoinduction for the Enantiopure Synthesis of Substituted-2-Cyclopentenones
Arisetti, Nanaji,Reiser, Oliver
supporting information, p. 94 - 97 (2015/07/28)
The pseudoenantiomeric 4-O-Boc- and 4-OPMP-cyclopent-2-enones, readily available from hydroxymethylenefurane on multigram scale, are demonstrated to be exceptional building blocks for the synthesis of enantiopure 4-alkyl-5-(1′-hydroxyalkyl) substituted 2-cyclopentenones and derivatives thereof. The 4-OR substituent acts as a traceless stereoinducing element, conferring not only 1,2- but also 1,4-stereocontrol with excellent selectivity. The methodology developed here was applied for the rapid synthesis of natural products and biologically active 2-cyclopentenones such as TEI-9826, guaianes, and pseudoguaianolides. (Figure Presented).